Obalon Therapeutics, Inc.

[NASDAQ: OBLN]; based in Carlsbad, California; incorporated in Delaware

Deadline: 04/16/2018

Case #: 18-cv-352

Court: USDC, Southern District of California

Lead or Derivative; Class Period is 10/5/2016 to 1/23/2018